GO
Welcome to the NJSHP page for COVID-19 support

Click here for a message to all NJSHP members and our pharmacy colleagues from the NJSHP President

Please remember to always validate and verify all information as the information provided herein can be outdated due to the dynamic nature of the COVID-19 public health crisis.

NJ centric issues and concerns regarding COVID-19

During this time communication is critical. NJSHP would like to support the health-system members and residents of New Jersey. 

Please send any suggested content to Stella Williams (swilliams@njha.com) so we can review and share them as appropriate.


NJ BOP and NJ DOH links and resources

The Board of Pharmacy and the Department of Health have information on COVID-19

RSS


ASHP has consolidated information on COVID-19

Click here to view the provided resources

Quick Links

NJBOP

NJDOH

ASHP

CDC

FDA

USP

WHO

General Information

Useful links on COVID-19 resources

John Hopkins University

Current UW Medicine protocols:
UW Medicine 

Wolters Kluwer

Penn Medicine's treatment guidelines

Michigan Medicine treatment guidelines

Drug and Prescription Updates Recent publications on medication management with COVID-19

Drug diversion by the DEA

ACE Inhibitors and ARBs use

Darunavir treatment lacking evidence

USP/Compounding Updates In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of USP compounding standards and the compounding of alcohol-based sanitizers for consumer use.

The USP Compounding Expert Committee developed the following information resources that may be of assistance during this public health emergency:

- Compounding Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic

- USP Response to Shortages of Garb and PPE for Sterile Compounding During the COVID-19 Pandemic

Any additional questions should be directed to the USP Healthcare Quality and Safety staff at compoundingsl@usp.org